Praktische Endokrinologie für die Schwangerschaft und die Stillzeit

  • Freimut A. Leidenberger

Zusammenfassung

Das vorliegende Kapitel ist den praktischen Fragen der Schwangerschaftsendokrinologie gewidmet, nachdem in Kap. 6 die normalen endokrinen Funktionen während der Schwangerschaft als Basis für das Verständnis pathophysiologischer Zusammenhänge dargestellt wurden. Die folgenden Ausführungen sollen vor allem zeigen, mit welchen Parametern eine Schwangerschaftsdiagnose oder prognostische Aussage zur Schwangerschaft möglich ist, wie zuverlässig diese ist und welche klinischen Konsequenzen sich hieraus ergeben können. Ferner werden in diesem Kapitel Erkrankungen endokriner Organe während der Schwangerschaft beschrieben, soweit sie für die Praxis relevant sind. Schließlich soll einigen wichtigen Fragen nachgegangen werden, die im Zusammenhang mit einer Hormonmedikation in der Schwangerschaft und Stillzeit auftreten können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adlercreutz H, Tikkanen MJ, Wichmann K, Avanborg A, Anberg A (1974) Recurrent jaundice in pregnancy. IV. quantitative determination of urinary estrogens including studies in pruritus gravidarum. J Clin Endocrinol Metab 38: 51PubMedCrossRefGoogle Scholar
  2. Adlercreutz H, Martin F, Lehtinen T, Tikkanen MJ, Pulkkinen MO (1977) Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy. Am J Obstet Gynecol 128: 266PubMedGoogle Scholar
  3. Aono T, Aki T, Koike K et al. (1982) Effect of sulpiride on poor puerperal lactation. Am J Obstet Gynecol 143: 927PubMedGoogle Scholar
  4. Artner J, Irsigler K, Ogris E, Rosenkranz A et al. (1981) Diabetes und Schwangerschaft. Z Geburtsh Perinatol 1985: 125Google Scholar
  5. Asche van FA, Hoet JJ, Jack PM (1976) The endocrine pancreas of the pregnant mother, fetus and newborn. In: Beard RW, Nathanielsz PW (eds) Fetal physiology and medicine. Saunders, Philadelphia, p 121Google Scholar
  6. Bacigalupo G, Saling EZ, Gesche J (1982) Paired measurements of total and unconjugated estriol in maternal plasma during the 2nd and 3rd trimester of pregnancy — their relationship to intrauterine growth retardation. J Perinat Med 10: 73PubMedCrossRefGoogle Scholar
  7. Bayes ET (1963) An assay towards solving a problem in the doctrine of chance. Philos Trans R Soc Lond [Biol] 53: 370Google Scholar
  8. Beaufils M, Donsimoni R, Uzan S, Colau JC (1985) Prevention of preeclampsia by early antiplatelet therapy. Lancet I: 840CrossRefGoogle Scholar
  9. Beischer NA, Brown JB (1972) Current status of estrogen assays in obstetrics and gynecology. Review. Obstet Gynecol Survey 27: 303Google Scholar
  10. Bellmann O (1983) Schwangerschaftsproteine — klinische Relevanz in der Spätschwangerschaft. Gynäkologe 16: 132PubMedGoogle Scholar
  11. Berle P, Behnke K (1977) Über Behandlungserfolge der drohenden Fehlgeburt. Geburtshilfe Frauenheilkd 37: 139PubMedGoogle Scholar
  12. Bernard RM (1977) Studies on lactation and contraception in WHO’s research programme. J Biosocial Sci [Suppl] 4: 113CrossRefGoogle Scholar
  13. Bohnet HG, Gomez F, Friesen HCG (1977) Prolactin and estrogen binding sites in the mammary gland of the lactating and non-lactating rat. Endocrinology 101: 1111PubMedCrossRefGoogle Scholar
  14. Bradford WUP, Hargreaves T (1978) Human placental lactogen in late pregnancy. Lancet I: 1213CrossRefGoogle Scholar
  15. Brook CGD (1981) Congenital adrenal hyperplasia. In: Brook CGD (eds) Clinical paediatric endocrinology. Blackwell Scientific, Oxford, p 453Google Scholar
  16. Brown MJ (1983) Current practice: catecholamine measurements in clinical medicine. Postgrad Med J 59: 479PubMedCrossRefGoogle Scholar
  17. Bryson PSC (1983) β-subunit of human chorionic gonadotropin, ultrasound, and ectopic pregnancy: a prospective study. Am J Obstet Gynecol 146: 163PubMedGoogle Scholar
  18. Chapman MG, Jones WR (1978) Pregnancy-specific β-1 glycoprotein (SP-1) in normal and abnormal pregnancy. Aust NZ J Obstet Gynaecol 18: 172CrossRefGoogle Scholar
  19. Chard T, Klopper A (1982) Placental function tests. Springer, Berlin Heidelberg New York Tokyo p 64CrossRefGoogle Scholar
  20. Check JH, Adelson HG (1987) The efficacy of progesterone in achieving successful pregnancy: II. In women with pure luteal phase defects. Int J Fertil 32: 139PubMedGoogle Scholar
  21. Check JH, Chase JS, Wu Ch-H, Adelson HG, Teichmann M, Rankin A (1987) The efficacy of progesterone in achieving successful pregnancy: I. Prophylactic use during luteal phase in anovulatory women. Int J Fertil 32: 135PubMedGoogle Scholar
  22. Clark D, Seeds JW, Cefado RC (1981) Hyperparathyroid crisis and pregnancy. Am J Obstet Gynecol 140: 840PubMedGoogle Scholar
  23. Dati F (1981) Schwangerschaftsproteine: Diagnostische Bedeutung in der Schwangerschaftsüberwachung und Tumordiagnostik, mta 3: 238Google Scholar
  24. Deftos LJ, First BP (1981) Diagnosis and treatment: drugs five years later — calcitonin as a drug. Ann Intern Med 95: 192PubMedGoogle Scholar
  25. Delaney JJ, Ptacek J (1970) Three decades of experience with diabetic pregnancies. Am J Obstet Gynecol 106: 550PubMedGoogle Scholar
  26. Deutsch AA, Bernheim J, Zager M, Steiner Z, Reiss R (1980) The diagnosis and management of hyperparathyroidism during pregnancy. Postgrad Med J 56: 333PubMedCrossRefGoogle Scholar
  27. Dixon HG, Browne JCM, Davey DA (1963) Choriodecidual and myometrial blood flow. Lancet I: 369CrossRefGoogle Scholar
  28. Duchesne C, Leke R (1981) Bromocriptine mesylate for prevention of lactation. Obstet Gynecol 57: 464PubMedGoogle Scholar
  29. Edwards PR, Diver MJ, Davis JC, Hipkin LJ (1976) Plasma oestriol and human placental lactogen measurements in patients with high risk pregnancies. Br J Obstet Gynaecol 83: 229PubMedCrossRefGoogle Scholar
  30. Eiermann W, Albrich W, Dati F, Leis D, Eicher W (1981) SP-1-Enzymimmunoassay: klinische Anwendung I. Schwangerschaftsfrühdiagnostik. Geburtshilfe Frauenheilkd 41: 404PubMedCrossRefGoogle Scholar
  31. Eskes KAB, Nijdam WS (1984) Epidemiology of drug intake during pregnancy. In: Krauer B, Krauer F, Hytten FE, del Pozo E (eds) Drugs and pregnancy. Maternal drug handling fetal drug exposure. Academic Press, London, p 17Google Scholar
  32. Fliegner JRH, Schindler I, Brown JB (1972) Low urinary oestriol excretion during pregnancy associated with placental sulphatase deficiency or congenital adrenal hypoplasia. J Obstet Gynaecol Br Commonw 79: 810PubMedCrossRefGoogle Scholar
  33. France JT, Seddon RJ, Liggins GC (1973) A study of a pregnancy with low estrogen production due to placental sulfatase deficiency. J Clin Endocrinol Metab 36: 1PubMedCrossRefGoogle Scholar
  34. Fritz MA, Guo S (1987) Doubling time of human chorionic gonadotropin (hCG) in early normal pregnancy: relationship to hCG concentration and gestational age. Fertil Steril 47: 584PubMedGoogle Scholar
  35. Gabbe SG (1985) Management of diabetes mellitus in pregnancy. Am J Obstet Gynecol 153: 824PubMedGoogle Scholar
  36. Gerner R, Halberstadt E (1980) Das Verhalten endokriner Parameter unter der Membranprophylaxe mit Glucocorticoiden. Z Geburtshilfe u Perinatol 184: 262Google Scholar
  37. Gethmann U (1980) Plamsakonzentrationen von unkonjugier-tem Östriol bei Schwangeren. Ärztl Lab 26: 205Google Scholar
  38. Gezelle de H, Ooghe W, Thiery M, Dhont M (1983) Metoclopramide and breast milk. Europ J Obstet Gynec Reprod Biol 15: 31Google Scholar
  39. Gips H, Braun H (1983) Diagnose der fetalen Gefährdung. Arch Gynaecol 235: 540CrossRefGoogle Scholar
  40. Gjessing LR (1968) Biochemistry of functional neural crest tumors. In: Bodansky O, Stewart CP (eds) Advances in clinical chemistry, vol 11. Academic Press, London, p 81Google Scholar
  41. Glass RH, Jesurum HM (1966) Immunologic pregnancy tests in ectopic pregnancy. Obstet Gynecol 27: 66PubMedGoogle Scholar
  42. Goebel R (1978) Biochemical parameters for surveillance of high-risk pregnancies. Hormone Res 9: 339PubMedCrossRefGoogle Scholar
  43. Goebel R, Rjosk HK, Kuss E (1975) Diagnostische Wertigkeit der Serumöstrogenbetimmung im Vergleich mit anderen chemischen Überwachungsmethoden bei Risikoschwangerschaften. In: Dudenhausen JW, Saling E, Schmidt E (Hrsg) Perinatale Medizin. Thieme, Stuttgart, S 143Google Scholar
  44. Gormley MJJ, Hadden DR, Kennedy TL, Montgomery DAD, Murnaghan GA, Sheridan B (1982) Cushing’s syndrome in pregnancy — treatment with metyrapone. Clin Endocrinol 16: 283CrossRefGoogle Scholar
  45. Gray RH, Campbell OM, Apelo R et al. (1990) Risk of ovulation during lactation. Lancet 335: 25PubMedCrossRefGoogle Scholar
  46. Grimes EM, Fayez JA, Miller GL (1973) Cushing’s syndrome and pregnancy. Obstet Gynecol 42: 550PubMedCrossRefGoogle Scholar
  47. Hamilton DV, Pryor JS (1981) Endocrine abnormalities in primary hyperparathyroidism. Postgrad Med J 57: 167PubMedCrossRefGoogle Scholar
  48. Hammerstein J (1978) Mißbildungen nach Behandlung schwangerer Frauen mit weiblichen Sexualhormonen. Endokrinologie-Informationen 2: 102, Dtsch Ärztebl 75: 1751Google Scholar
  49. Hansmann M (1976) Ultraschallbiometrie im II. und III. Trimester der Schwangerschaft. Gynäkologe 9: 133Google Scholar
  50. Harforche JK (1977) Appearance of contraceptive steroids in human milk: effect on the child. J Biosoc Sci [Suppl] 4: 165CrossRefGoogle Scholar
  51. Haukamaa M, Gummerus M (1982) Decrease of serum oestriol during intravenous hexoprenaline or salbutamol treatment. Br J Obstet Gynaecol 89: 917CrossRefGoogle Scholar
  52. Hayslip C, Klein TA, Wray HL, Duncan WE (1989) The effects of lactation on bone mineral content in healthy postpartum women. Obstet Gynecol 73: 588PubMedGoogle Scholar
  53. Hell van H, Helmich J (1985) The evolution of pregnancy testing — applications of monoclonal technology. In: Int Clin Products, Jan/Feb: 26Google Scholar
  54. Home CHW, Bremner RD, Jandial V, Glover RG, Towler CM (1979) Practical and theoretical considerations in the measurement of pregnancyspecific β1 glycoprotein. In: Klopper A, Chard T (eds) Placental proteins. Springer, Berlin Heidelberg New York Tokyo, p 143Google Scholar
  55. Hull MGR (1976) The basis and application of estrogen essays on urine and blood to assess fetoplacental function in late pregnancy. J Perinat Med 4: 137PubMedCrossRefGoogle Scholar
  56. Hull VJ (1987) Breast-feeding and fertility: the sociocultural context. Int J Gynecol Obstet [Suppl] 25: 77CrossRefGoogle Scholar
  57. Isouard G (1981) A comparison of serum measurements of unconjugated oestriol, total oestriol, human placental lactogen and pregnancy-specific β1 glycoprotein in the assessment of fetal wellbeing. Aust J Med Lab Sci 2: 85Google Scholar
  58. Jandial V, Towler CM, Home CHW, Abramovich DR (1978) Plasma pregnancy specific β1-glycoprotein in complications of early pregnancy. Br J Obstet Gynaecol 85: 832PubMedCrossRefGoogle Scholar
  59. Jones HW Jr (1979) A long look at the adrenogenital syndrome. John Hopkins Med J 145: 143Google Scholar
  60. Jouppila P, Seppälä M, Chard T (1980) Pregnancy specific β1-glycoprotein in complications of early pregnancy. Lancet I: 667Google Scholar
  61. Jung H, Klöck FK (1967) Zur Prognose und Therapie der drohenden Fehlgeburt und die Ergebnisse nach erhaltener Schwangerschaft. Geburtshilfe Frauenheilkd 27: 461PubMedGoogle Scholar
  62. Kadar N, De Vore G, Romero R (1981) Discriminatory hCG zone: its use in the sonographic evaluation for ectopic pregnancy. Obstet Gynecol 58: 156PubMedGoogle Scholar
  63. Kauppila A, Kivinen S, Ylikorkala O (1981) Metoclopramide increases prolactin release and milk secretion in puerperium without stimulating the secretion of thyrotropin and thyroid hormones. J Clin Endocrinol Metab 52: 436PubMedCrossRefGoogle Scholar
  64. Kajii T, Ferrier A, Niikawa N, Takahara A, Ohama K, Avirachan S (1980) Anatomic and chromosomal anomalies in 639 spontenous abortuses. Hum Genet 55: 87PubMedCrossRefGoogle Scholar
  65. Kenney A, Woodforde Scott J, Hall CA (1978) Human placental lactogen in late pregnancy. Lancet II: 209CrossRefGoogle Scholar
  66. Kjer JJ, Hess J (1983) Serum estriol levels during treatment with betamethasone in the last trimester of human pregnancy. Acta Obstet Gynecol Scand 62: 307PubMedCrossRefGoogle Scholar
  67. Kleinebrecht J, Franz J (1986) Arzneimittel in der Schwangerschaft. Wissensch Verlagsbuchhandlung, StuttgartGoogle Scholar
  68. Klopper A (1968) The assessment of feto-placental function by estriol assay. Obstet Gynecol Surv 23: 813CrossRefGoogle Scholar
  69. Klopper A (1985) Kontrolle der Frühschwangerschaft durch Plazentaproteinbestimmung. Diagnose u. Labor 35: 178Google Scholar
  70. Knapstein P, Melchert F (1978) Biochemische Überwachung der Risikoschwangerschaft. Gynäkologe 11: 151Google Scholar
  71. Knoll E, Kayser A, Wisser H (1978) Verhalten von Gesamtöstriol, nichtkonjugiertem Östriol, Human-Placenta-Lactogen und Oxytocinase im Serum sowie der Gesamtöstrogene im Urin von schwangeren Frauen nach Gabe von Betamethason. J Clin Chem Clin Biochem 16: 621PubMedGoogle Scholar
  72. Kram I, Slachmuylder E, van Peborgh J, Brauman H, Hechtermans R, Maamari R, Levi S (1977) The intrauterine diagnosis of PIFG by combined hormonal and ultrasonic approach. In: Salvadori B, Modena AB (eds) Poor intrauterine fetal growth. Minerva Medica, Parma, p 271Google Scholar
  73. Kiinzig HJ (1985) Hormonbestimmungen. In: Dudenhausen JW (Hrsg) Praxis der Perinatalmedizin. Thieme, Stuttgart, S 73Google Scholar
  74. Kunz J, Keller PJ (1976) Ultrasound and biochemical findings in intrauterine growth retardation. J Perinat Med 4: 85PubMedCrossRefGoogle Scholar
  75. Kunz J, Schreiner WE (1982) Pharmakotherapie während Schwangerschaft und Stillperiode. Thieme, StuttgartGoogle Scholar
  76. Lang N, Bellmann O (1977) Kritische Analyse des heutigen Stands der fetalen Risikoerkennung in der Schwangerschaft durch Hormonbestimmungen. Z Geburtshilfe u Perinatol 181: 303Google Scholar
  77. Lang N, Bellmann O, Hansmann M, Nocke W, Niesen M (1977) Klinik und Diagnostik der intrauterinen Mangelentwicklung. Fortschr Med 95: 482PubMedGoogle Scholar
  78. Lau HL, Lawrence KW, Linkins S, Jones GS (1978) Early detection of human chorionic gonadotropin in urine by simple immunoassays. Am J Obstet Gynecol 132: 691PubMedGoogle Scholar
  79. Laube H (1985) Hat sich die Bestimmung von Hb-A1 in der Diabeteskontrolle bewährt? Dtsch Med Wochenschr 110: 823PubMedCrossRefGoogle Scholar
  80. Lauritsen JG (1976) Etiology of spontaneous abortions. A cytogenetic and epidemiological study of 288 abortuses and their parents. Acta Obstet Gynecol Scand [Suppl] 51: 1CrossRefGoogle Scholar
  81. Lauritzen C (1985) Medikamente in der Schwangerschaft. Auch im 2. und 3. Trimenon sowie in der Stillzeit ist große Umsicht geboten. Gyne 9: 292Google Scholar
  82. Lehmann WD, Jonatha W, Forstner HA, Neumann KG, Pohlandt F (1978) Fortschritte in der Diagnostik und Behandlung bei Schwangerschaften mit untergewichtigen Kindern. Geburtshilfe Frauenheilkd 38: 606PubMedGoogle Scholar
  83. Lönnerdal B, Forsum E, Hambraeus L (1980) Effect of oral contraceptives on composition and volume of breast milk. Am J Clin Nutr 33: 816PubMedGoogle Scholar
  84. Long PA, Abell DA, Beischer NA (1979) Fetal growth and placental function assessed by urinary estriol excretion before the onset of preeclampsia. Am J Obstet Gynecol 135: 344PubMedGoogle Scholar
  85. Low JA, Galbraith RS (1974) Pregnancy characteristics of intrauterine growth retardation. Obstet Gynecol 44: 122PubMedGoogle Scholar
  86. Mario di MS, Baumgarten A, Greenstein RM et al. (1987) Screening for fetal Down’s syndrome in pregnancy by measuring maternal serum alpha — fetoprotein levels. N Engl J Med 317: 342CrossRefGoogle Scholar
  87. Melchert F (1978) Biochemisch-immunologische Möglichkeiten der Schwangerschaftsüberwachung. Thieme Copythek, Thieme, Stuttgart, S 97Google Scholar
  88. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE (1984) An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148: 886PubMedGoogle Scholar
  89. Mirmiran M (1982) Experimental studies on the significance of active (c. q.REM)-sleep for maturation of brain and behavior in the rat. Thesis Netherlands Institute for Brain Research, University of AmsterdamGoogle Scholar
  90. Mishell DR, Nakamura RM, Barberia JM, Thorneycroft IH (1974) Initial detection of human chorionic gonadotropin in serum in normal human gestation. Am J Obstet Gynecol 118: 990PubMedGoogle Scholar
  91. Morrison I, Green P, Oomen B (1980) The role of human placental lactogen assays in antepartum fetal assessment. Am J Obstet Gynecol 136: 1055PubMedGoogle Scholar
  92. Nabarro J, Brook C (1975) Diseases of the adrenal cortex. Medicine 8: 351Google Scholar
  93. Nars PW (1982) Medikamente in der Stillperiode. Gynäkologe 15: 166PubMedGoogle Scholar
  94. Nerup J (1974) Addison’s disease — clinical studies. A report of 108 cases. Acta Endocrinol 76: 127PubMedGoogle Scholar
  95. Neville MC, Neifert MR (1983) Lactation. Physiology, nutrition, and breast-feeding. Plenum, New YorkGoogle Scholar
  96. Niederau CM, Potthoff S, Reinauer H (1981) Hyperglykämie als Risikofaktor in der Schwangerschaft. Z Geburtshilfe u Perinatol 185: 137Google Scholar
  97. Nilsson S, Nygren K, Johansson EDB (1977) d-Norgestrel concentrations in maternal plasma, milk and child plasma during administration of oral contraceptives to nursing women. Am J Obstet Gynecol 129: 179Google Scholar
  98. Nilsson S, Nygren K, Johansson EDB (1979) Ethinyl estradiol in human milk and plasma after oral administration. Contraception 17: 131CrossRefGoogle Scholar
  99. Nolin JM, Bogdanove EM (1980) Effects of estrogen on prolactin incorporation by lutein and milk secretory cells and on pituitary prolactin secretion in the postpartum rat: correlation in target cell responsiveness to prolactin. Biol Reprod 22: 393PubMedGoogle Scholar
  100. Ohrlander SAV, Gennser GM, Grennert L (1975) Impact of betamethasone load given to pregnant women on endocrine balance of fetoplacental unit. Am J Obstet Gynecol 123: 228PubMedGoogle Scholar
  101. Ozturk M, Bellet D, Manil L, Hennen G, Frydman R, Wands J (1987) Physiological studies of human chorionic gonadotropin (hCG), αhCG, and ßhCG as measured by specific monoclonal immunoradiometric assays. Endocrinology 120: 549PubMedCrossRefGoogle Scholar
  102. Paulin F, Csömör S (1982) Die Veränderungen der Östriolausscheidung im Harn und der Nierenfunktion während Partusisten-Infusion. Z Geburtshilfe u Perinatol 186: 244Google Scholar
  103. Peters F (1984) Aspekte der Physiologie und Pathologie der Laktation. In: Breckwoldt M (Hrsg) Endokrinologie in der Schwangerschaft. Deutscher Ärzte-Verlag, Köln, S 169Google Scholar
  104. Peters F (1989) Laktation und Wochenbett. In: Bettendorf G, Breckwoldt M (Hrsg) Reproduktionsmedizin. Fischer, Stuttgart, S 603Google Scholar
  105. Peters F, Geisthövel F, Breckwoldt M (1985) Serum prolactin levels in women with excessive milk production. Normalization by transitory prolactin inhibition. Acta Endocrinol (Copenh) 109: 463Google Scholar
  106. Pittaway DE, Wentz AC (1985) Evaluation of early pregnancy by serial chorionic gonadotropin determinations: a comparison of methods by receiver operating characteristic curve analysis. Fertil Steril 43: 529PubMedGoogle Scholar
  107. Prema K (1981) Effect of hormonal contraceptives and IUDs on lactation and return of menstruation in lactating women, Contraceptive Delivery Systems. Zitiert in: Breastfeeding, fertility and familiy planning. Popul Rep [J] 24: 558Google Scholar
  108. Ramzin MS (1982) Teratogene Wirkung von Medikamenten. Gynäkologe 15: 136PubMedGoogle Scholar
  109. Reck G (1984) Periphere Hormone in der Spätschwangerschaft. In: Breckwoldt M (Hrsg) Endokrinologie in der Schwangerschaft. Deutscher Ärzte-Verlag, Köln, S 97Google Scholar
  110. Romero R, Kadar N, Copel JA, Jeanty Ph, DeCherney AH, Hobbins JC (1985) The effect of different human chorionic gonadotropin assay sensitivity on screening for ectopic pregnancy. Am J Obstet Gynecol 153: 72PubMedGoogle Scholar
  111. Ruckhäberle KE, Viehweg B, Schlegel CH, Ruckhäberle B, Weißbach R, Schürer K (1979) Zur klinischen Wertigkeit verschiedener Parameter bei der antenatalen Diagnostik der fetalen Hypotrophie. Zentralbl Gynäkol 101: 523PubMedGoogle Scholar
  112. Ruis H, Rolland R, Doesburg W, Broeders G, Corbey R (1981) Oxytocin enhances onset of lactation among mothers delivering prematurely. Br Med J 283: 340CrossRefGoogle Scholar
  113. Runnebaum B (1984) Störungen in der Frühschwangerschaft. Verh Dtsch Ges Gynäkol: In Arch Gynecol Obstet 238: 709Google Scholar
  114. Runnebaum B, Gerhard I (1983) Diagnostische und prognostische Bedeutung von Hormonbestimmungen in der ersten Schwangerschaftshälfte. Gynäkologe 16: 155PubMedGoogle Scholar
  115. Rutanen EM, Tarjanne H, Huovinen J, Ikonen M (1980) hCG-βsubunit radioimmunoassay in gynaecological emergencies. Lancet I: 484CrossRefGoogle Scholar
  116. Ryan M, Gray BC (1975) Estrogen analysis in pregnancy urine, an artifact corrected. Clin Chim Acta 60: 197PubMedCrossRefGoogle Scholar
  117. Ryden G (1978) The value of serum cystine aminopeptidase (CAP), human chorionic somatomammotrophin (HCS), and urinary oestrogen assays for detecting intrauterine growth retardation. Acta Obstet Gynecol Scand 57: 211PubMedCrossRefGoogle Scholar
  118. Sandvei R, Stoa KF, Ulstein M (1981) Radioimmunoassay of human chorionic gonadotropin β-subunit as an early diagnostic test in ectopic pregnancy. Acta Obstet Gynecol Scand 60: 389PubMedCrossRefGoogle Scholar
  119. Saxena BN, Shrimanker K, Grudzinskas JG (1977) Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception 10: 605CrossRefGoogle Scholar
  120. Schmidt W, Kubli F, Garoff L, Hendrik HJ, Leucht W, Runnebaum B (1982) Diagnose der intrauterinen Wachstumsretardierung — Vergleich von Klinik, Gesamtöstrogenbestimmung aus dem 24h-Urin und Ultraschallbiometrie (Distanzmessungen, biparietaler Kopfdurchmesser und thorako-abdominaler Querdurchmesser) unter Berücksichtigung des antepartalen und subpartalen CTGs. Geburtshilfe Frauenheilkd 42: 709PubMedCrossRefGoogle Scholar
  121. Schmidt W, Klinga K, Neudeck K, Runnebaum B, Kubli F (1983) Die ektopische Schwangerschaft — Wertigkeit der Serumß-HCG-und β1-Glykoprotein(SP1)-Bestimmung. Geburtshilfe Frauenheilkd 43: 664PubMedCrossRefGoogle Scholar
  122. Schultz-Larsen P, Hertz JB (1978) The predictive value of pregnancy-specific β1-glycoprotein (SP1) in threatened abortion. Eur J Obst Gyn Rep Biol 8: 253CrossRefGoogle Scholar
  123. Schwallie PC (1981) The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review. Contraception 23: 375PubMedCrossRefGoogle Scholar
  124. Schwartz RO, DiPietro DL (1980) β-hCG as a diagnostic aid for suspected ectopic pregnancy. Obstet Gynecol 56: 197PubMedGoogle Scholar
  125. Sérey CT, Saling E (1980) HPL-Verhalten im mütterlichen Serum nach langzeitiger Gabe von Xantinol-Nicotinat (Complamin retard). Z Geburtshilfe u Perinatol 184: 283Google Scholar
  126. Shearman RP, Garrett WJ (1963) Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate. Br Med J 2: 292CrossRefGoogle Scholar
  127. Sheppard BL, Bonnar J (1976) The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol 83: 948PubMedCrossRefGoogle Scholar
  128. Spellacy WN (1977) Insulin, glucagon, and growth hormone in pregnancy. In: Fuchs F, Klopper A (eds) Endocrinology of pregnancy, 2nd edn. Harper & Row, New York, p 206Google Scholar
  129. Spellacy WN, Buhi WC, Birk SA (1975) The effectiveness of human placental lactogen measurements as an adjunct in decreasing perinatal deaths. Am J Obstet Gynecol 121: 835PubMedGoogle Scholar
  130. Spellacy WN, Buhi WC, Birk SA (1978) Human placental lactogen levels in multiple pregnancies. Obstet Gynecol 52: 210PubMedGoogle Scholar
  131. Spuy van der ZM, Jacobs HS (1984a) Management of endocrine disorders in pregnancy. Part I — thyroid and parathyroid disease. Postgrad Med J 60: 245PubMedCrossRefGoogle Scholar
  132. Spuy van der ZM, Jacobs HS (1984b) Management of endocrine disorders in pregnancy. Part II — pituitary, ovarian and adrenal disease. Postgrad Med J 60: 312PubMedCrossRefGoogle Scholar
  133. Stahlmann R, Neubert D (1985) Welche Medikamente in der Schwangerschaft? In: Künzel G (Hrsg) Gießener Fortbildungstage. Springer, Berlin Heidelberg New York Tokyo, p 59Google Scholar
  134. Ström H, Berg B, Jacobson L (1983) Plasma estriol in late pregnancy in relation of fetal outcome. Acta Obstet Gynecol Scand 62: 355PubMedCrossRefGoogle Scholar
  135. Tatra G, Bernaschek G, Tessarek KH (1983) SP-1 bei normaler und gestörter Frühschwangerschaft. Diagnostik durch Enzymimmunoassay. Geburtshilfe Frauenheilkd 43: 224PubMedCrossRefGoogle Scholar
  136. Tindall VR (1968) Factors influencing puerperal thromboembolism. J Obstet Gynaec Br Com 75: 1324CrossRefGoogle Scholar
  137. Toddywalla VS, Joshi L, Virkar K (1977) Effect of contraceptive steroids on human lactation. Am J Obstet Gynecol 127: 245PubMedGoogle Scholar
  138. Towler CM, Home CHW, Jandial V, Campbell DM, MacGillivray I (1977) Plasma levels of pregnancy specific β1-glycoprotein in complicated pregnencies. Br J Obstet Gynaecol 84: 258PubMedCrossRefGoogle Scholar
  139. Trolle D, Gaede P, Pedersen H (1978) Human placental lactogen in late pregnancy. Lancet II: 105CrossRefGoogle Scholar
  140. Tulchinsky D (1981) The role of maternal and fetal hormones in pregnancy. Contemp Obstet Gynecol 17: 113Google Scholar
  141. Varga L, Radielovic P (1974) Postpartale Laktationshemmung durch 2Bα-Ergokryptin: II. Eine Vergleichsuntersuchung mit 2BRα-Ergokryptin und Methalleenöstrol. Geburtshilfe Frauenheilkd 34: 885PubMedGoogle Scholar
  142. Wald NJ, Cuckle HS, Densem JW et al. (1988a) Maternal serum screening for Down’s syndrome in early pregnancy. Br Med J 297: 883CrossRefGoogle Scholar
  143. Wald NJ, Cuckle HS, Densem JW et al. (1988b) Maternal serum unconjugated oestriol as an antenatal screening test for Down’s syndrome. Br J Obstet Gynaecol 95: 334PubMedCrossRefGoogle Scholar
  144. Watanabe F, Nakahara M, Tsubota N, Tsukida K, Saiki K, Ito M (1978) Mechanism for interference of hydrochlorothiazide with the Kober reaction for determination of urinary estriol in pregnancy. Clin Chim Acta 88: 21PubMedCrossRefGoogle Scholar
  145. Weitzel H (1983) Alpha-Fetoprotein in der Geburtshilfe. Gynäkologe 16: 148PubMedGoogle Scholar
  146. Westergaard JG, Teisner B, Hau J, Grudzinskas JG (1984) Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation. Br J Obstet Gynaecol 91: 1216PubMedCrossRefGoogle Scholar
  147. White P (1974) Diabetes mellitus in pregnancy. Clin Perinatol 1: 331PubMedGoogle Scholar
  148. Whittle MJ, Anderson D, Lowensohn RI, Mestman JH, Paul RH, Goebelsmann U (1979) Estriol in pregnancy. Experience with unconjugated plasma estriol assays and antepartum fetal heart rate testing in diabetic pregnancies. Am J Obstet Gynecol 135: 764PubMedGoogle Scholar
  149. Wisser H, Knoll E, Hartmann G, Kayser A (1979) Diurnal variations of estriol and Cortisol in serum and urine in late pregnancy with and without fenoteroltherapy. Clin Chim Acta 92: 221PubMedCrossRefGoogle Scholar
  150. Wolfrum R (1980) Gesamtöstrogene und Pregnandiol im 24h-Urin. Ein System zur Frühdiagnose bei fetoplazentarem Risiko. Ärztl Lab 26: 129Google Scholar
  151. Wolfrum R, Pahnke V (1980) Humanes plazentares Laktogen bei Hypotrophie. Ärztl Lab 26: 213Google Scholar
  152. Wolfrum R, Bordasch C, Holweg J, Schulz G, Schulz U, Oelkers W (1977) Prognostic value of combined assay of total estrogen and pregnandiol in 24h urine. Experience with 500 pregnancies in an endocrine surveillance program during the second trimester. J Perinat Med 5: 133PubMedCrossRefGoogle Scholar
  153. Wolfrum R, Gethmann U (1980) dU-Gesamtöstrogene, S-Un-konjugiertes Östriol und S-Gesamtöstriol bei Hypotrophie. Ein Vergleich der klinischen Relevanz auf quantitativer Basis. Z Geburtshilfe u Perinatol 184: 413Google Scholar
  154. Wulf KH (1977) Potential of betamimetic therapy in placental insufficiency. In: Weidinger H (Hrsg) Labour inhibition by betamimetic drugs in obstetrics. Fischer, Stuttgart, p 203Google Scholar
  155. Wulf KH (1981) Das Plazentainsuffizienzsyndrom (Ein klinisches Konzept). Z Geburtshilfe u Perinatol 185: 2Google Scholar
  156. Yogman MW, Speroff L, Huttenlocher PR, Kase NG (1972) Child development after pregnancies complicated by low urinary estriol excretion and pre-eclampsia. Am J Obstet Gynecol 114: 1069PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • Freimut A. Leidenberger
    • 1
  1. 1.Institut für Hormon- und FortpflanzungsforschungHamburg 50Deutschland

Personalised recommendations